US2837464A
(en)
*
|
1955-01-11 |
1958-06-03 |
Schering Corp |
Process for production of dienes by corynebacteria
|
DE1059906B
(de)
|
1954-10-05 |
1959-06-25 |
Scherico Ltd |
Verfahren zur Herstellung von 1, 4-Pregnadienen
|
US3067197A
(en)
*
|
1961-04-26 |
1962-12-04 |
Pfizer & Co C |
11-oxygenated 6alpha-fluoro-16-methylene-delta-pregnenes and derivatives
|
GB1047518A
(en)
*
|
1963-06-11 |
1966-11-02 |
Glaxo Lab Ltd |
17ª-monoesters of 11,17,21-trihydroxy steroid compounds
|
GB1159490A
(en)
*
|
1966-02-09 |
1969-07-23 |
Boots Pure Drug Co Ltd |
Improvements in Acylated Steroids
|
US3639434A
(en)
*
|
1967-02-02 |
1972-02-01 |
Boots Pure Drug Co Ltd |
17-acyloxysteroids and their manufacture
|
IT1061787B
(it)
|
1967-03-01 |
1983-04-30 |
Vismara Francesco Spa |
Miglioramenti relativi alla preparazione di 17 benzoato di betametazone
|
GB1227992A
(de)
*
|
1968-01-23 |
1971-04-15 |
Koninklijke Gist Spiritus |
|
IT1034011B
(it)
|
1969-06-26 |
1979-09-10 |
Vister Vismara Terapeutici S P |
Processo per la prapratzione di 17 monoesteri di 17 a 21 diossisteroidi per idrolisi die corpispondenti 17 21 ortoesteri ciclici a ph control lato
|
GB1384372A
(en)
|
1971-01-20 |
1975-02-19 |
Glaxo Lab Ltd |
Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids
|
CH572914A5
(de)
|
1971-01-22 |
1976-02-27 |
Asta Werke Ag Chem Fab |
|
US3813384A
(en)
|
1972-01-17 |
1974-05-28 |
Asta Werke Ag Chem Fab |
Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
|
US3828080A
(en)
*
|
1972-01-20 |
1974-08-06 |
Glaxo Lab Ltd |
Androstane-17beta-carboxylic acids and processes for the preparation thereof
|
US3989686A
(en)
*
|
1972-06-15 |
1976-11-02 |
Glaxo Laboratories Limited |
Anaesthetic steroids of the androstane series and process for preparing same
|
GB1438940A
(en)
*
|
1972-07-19 |
1976-06-09 |
Glaxo Lab Ltd |
17beta-haloalkoxycarbonyl-17alpha-oxysteroids
|
GB1440063A
(en)
*
|
1972-08-11 |
1976-06-23 |
Glaxo Lab Ltd |
17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids
|
US4093721A
(en)
*
|
1974-08-30 |
1978-06-06 |
Glaxo Laboratories Limited |
Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof
|
GB1517278A
(en)
|
1974-08-30 |
1978-07-12 |
Glaxo Lab Ltd |
Alkyl and haloalkyl androsta-1,4,15-triene and-4,15-diene-17beta-carboxylates
|
YU54476A
(en)
*
|
1975-03-31 |
1982-05-31 |
Taisho Pharmaceutical Co Ltd |
Process for obtaining 17-ester 21-halo-pregnane
|
CH628355A5
(de)
*
|
1976-02-24 |
1982-02-26 |
Ciba Geigy Ag |
Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.
|
US4221787A
(en)
*
|
1978-03-28 |
1980-09-09 |
Interx Research Corporation |
Esteramide prodrugs of anti-inflammatory corticosteroids
|
US4188385A
(en)
*
|
1978-04-05 |
1980-02-12 |
Syntex (U.S.A.) Inc. |
Thioetianic acid derivatives
|
US4187301A
(en)
*
|
1978-04-05 |
1980-02-05 |
Syntex (U.S.A.) Inc. |
17 Beta-thiocarboxylic acid esters of 6 alpha, 6 beta-difluoro-3-oxoandrost-4-enes
|
US4263289A
(en)
*
|
1978-04-05 |
1981-04-21 |
Syntex (U.S.A.) Inc. |
Thio etianic acid derivatives
|
US4261984A
(en)
*
|
1978-04-05 |
1981-04-14 |
Syntex (U.S.A.) Inc. |
17β-thiocarboxylic acid esters of 3-oxo-4-halo-16β-methylandrost-4-enes
|
US4198403A
(en)
*
|
1978-04-05 |
1980-04-15 |
Syntex (U.S.A.) Inc. |
17 Beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes
|
DE2817988A1
(de)
*
|
1978-04-25 |
1979-11-08 |
Hoechst Ag |
Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
|
US4310466A
(en)
*
|
1979-08-31 |
1982-01-12 |
Syntex (U.S.A.) Inc. |
Thio etianic acid derivatives
|
US4267173A
(en)
*
|
1979-11-05 |
1981-05-12 |
Schering Corporation |
Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
|
US4335121A
(en)
*
|
1980-02-15 |
1982-06-15 |
Glaxo Group Limited |
Androstane carbothioates
|
CY1291A
(en)
|
1980-02-15 |
1985-10-18 |
Glaxo Group Ltd |
Androstane 17 beta carbothioates
|
ZA814440B
(en)
|
1980-07-10 |
1982-10-27 |
Otsuka Pharma Co Ltd |
Soft steroids having anti-inflammatory activity
|
US4996335A
(en)
*
|
1980-07-10 |
1991-02-26 |
Nicholas S. Bodor |
Soft steroids having anti-inflammatory activity
|
SE449106B
(sv)
|
1980-07-10 |
1987-04-06 |
Otsuka Pharma Co Ltd |
Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
|
US4710495A
(en)
*
|
1980-07-10 |
1987-12-01 |
Otsuka Pharmaceutical Co., Ltd. |
Soft steroids having anti-inflammatory activity
|
CY1359A
(en)
*
|
1981-02-02 |
1987-08-07 |
Schering Corp |
Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
|
ZW6584A1
(en)
|
1983-04-18 |
1985-04-17 |
Glaxo Group Ltd |
Phenethanolamine derivatives
|
US4607028A
(en)
*
|
1983-08-18 |
1986-08-19 |
Ciba-Geigy Corporation |
Novel carboxylic acid esters
|
US4552899A
(en)
|
1984-04-09 |
1985-11-12 |
Analgesic Associates |
Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
|
EP0179583A1
(de)
|
1984-10-04 |
1986-04-30 |
Merck & Co. Inc. |
System zur Verbesserung der Auflösungsgeschwindigkeit in Wasser und der Löslichkeit von schwer löslichen Arzneimitteln
|
US4861765A
(en)
*
|
1985-06-26 |
1989-08-29 |
Jouveinal |
21-alkyl-, cycloalkyl- or aryl-substituted thio steroids and pharmaceutical compositions containing them
|
US4782047A
(en)
|
1986-05-22 |
1988-11-01 |
Syntex Pharmaceuticals International Ltd. |
Aqueous steroid formulations for nasal administration
|
ZA872389B
(en)
|
1987-04-02 |
1987-11-25 |
Advanced Polymer Systems Inc |
Composition and method for delivering a steroid active ingredient
|
ATE90355T1
(de)
|
1987-10-13 |
1993-06-15 |
Nicholas S Bodor |
Weiche steroide mit anti-entzuendungswirkung.
|
ES2053678T3
(es)
*
|
1987-11-13 |
1994-08-01 |
Asta Medica Ag |
Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular.
|
DE3836579A1
(de)
|
1987-11-13 |
1989-05-24 |
Asta Pharma Ag |
Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge
|
US5232919A
(en)
*
|
1987-11-13 |
1993-08-03 |
Asta Pharma Aktiengesellschaft |
Azelastine embonate and compositions which contain it
|
US5271946A
(en)
*
|
1988-04-20 |
1993-12-21 |
Asta Pharma Aktiengesellschaft |
Controlled release azelastine-containing pharmaceutical compositions
|
US4994439A
(en)
*
|
1989-01-19 |
1991-02-19 |
California Biotechnology Inc. |
Transmembrane formulations for drug administration
|
US5202316A
(en)
*
|
1989-03-22 |
1993-04-13 |
Roussel Uclaf |
N,N,N',N'-6-(1-piperazinyl)-2,5-pyridinediamines
|
FR2644788B1
(fr)
*
|
1989-03-22 |
1995-02-03 |
Roussel Uclaf |
Nouveaux steroides 3-ceto comportant une chaine en 17 amino-substituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
|
JPH07116215B2
(ja)
|
1989-04-19 |
1995-12-13 |
エスエス製薬株式会社 |
新規なステロイド化合物
|
ATE107643T1
(de)
|
1989-05-05 |
1994-07-15 |
Asta Medica Ag |
Salze des azelastins mit verbesserter löslichkeit.
|
EP0477195A1
(de)
|
1989-06-16 |
1992-04-01 |
The Upjohn Company |
Verbindungen des suramin-typs und angiostatische steroide zur verhütung der angiogenesis
|
IL95590A
(en)
|
1989-09-08 |
1996-06-18 |
Glaxo Group Ltd |
Medicinal preparations containing Salmetrol and Pluticasone Propionate
|
DE3931041C2
(de)
|
1989-09-16 |
2000-04-06 |
Boehringer Ingelheim Kg |
Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
|
DE4025342A1
(de)
*
|
1990-08-10 |
1992-02-13 |
Hoechst Ag |
In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel
|
JP3087763B2
(ja)
|
1990-11-30 |
2000-09-11 |
三井化学株式会社 |
新規な複素環式化合物およびそれを含有する医薬組成物
|
GB9103764D0
(en)
|
1991-02-22 |
1991-04-10 |
Glaxo Group Ltd |
Compositions
|
DE69231991T2
(de)
*
|
1991-06-10 |
2002-04-04 |
Schering Corp |
Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
|
US6127353A
(en)
*
|
1991-09-06 |
2000-10-03 |
Schering Corporation |
Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
|
US5658549A
(en)
*
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
NZ256346A
(en)
|
1992-10-09 |
1997-04-24 |
Procter & Gamble |
Medicaments containing 3-l-menthoxypropane-1,2-diol for treating cold symptoms
|
EP0620001A1
(de)
*
|
1993-04-16 |
1994-10-19 |
McNEIL-PPC, INC. |
Wässrige pharmazeutische Suspension und Verfahren zu ihrer Herstellung
|
DE4322703A1
(de)
|
1993-07-08 |
1995-01-12 |
Asta Medica Ag |
Druckgaspackungen unter Verwendung von Polyoxyethylen-glyceryl-fettsäureestern als Suspensionsstabilisatoren und Ventilschmiermittel
|
JP4208267B2
(ja)
|
1993-07-30 |
2009-01-14 |
キヤノン株式会社 |
制御装置
|
DE4328819A1
(de)
*
|
1993-08-27 |
1995-03-02 |
Hoechst Ag |
Corticosteroid-17-alkylcarbonat-21/0/-Carbonsäure- und Kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
|
DE4333920A1
(de)
*
|
1993-10-05 |
1995-04-13 |
Hoechst Ag |
Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
|
AU1093195A
(en)
|
1993-11-19 |
1995-06-06 |
Schering-Plough Healthcare Products, Inc. |
Nasal spray compositions containing oxymetazoline
|
US5576437A
(en)
|
1993-12-17 |
1996-11-19 |
The Procter & Gamble Company |
7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
|
US5420120A
(en)
*
|
1993-12-17 |
1995-05-30 |
Alcon Laboratories, Inc. |
Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
|
US5837699A
(en)
*
|
1994-01-27 |
1998-11-17 |
Schering Corporation |
Use of mometasone furoate for treating upper airway passage diseases
|
US5897858A
(en)
|
1994-02-03 |
1999-04-27 |
Schering-Plough Healthcare Products, Inc. |
Nasal spray compositions exhibiting increased retention in the nasal cavity
|
IL109656A
(en)
|
1994-05-15 |
1998-02-22 |
Chemagis Ltd |
Process for the manufacture of androstane - 17 - carbothioates and androstane - 17 - carbothioates prepared thereby
|
GB9410222D0
(en)
|
1994-05-21 |
1994-07-06 |
Glaxo Wellcome Australia Ltd |
Medicaments
|
GB9419536D0
(en)
*
|
1994-09-28 |
1994-11-16 |
Glaxo Inc |
Medicaments
|
AR002009A1
(es)
|
1994-12-22 |
1998-01-07 |
Astra Ab |
Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.
|
DE4446891A1
(de)
|
1994-12-27 |
1996-07-04 |
Falk Pharma Gmbh |
Stabile wäßrige Budesonid-Lösung
|
EP1166811B1
(de)
|
1995-04-14 |
2006-12-06 |
SmithKline Beecham Corporation |
Dosierinhalator für Fluticasonepropionat
|
JPH08291073A
(ja)
|
1995-04-22 |
1996-11-05 |
Kissei Pharmaceut Co Ltd |
医薬品組成物及びその製造方法
|
JPH08291072A
(ja)
|
1995-04-22 |
1996-11-05 |
Kissei Pharmaceut Co Ltd |
吸入用粉末製剤用結晶とその製造方法
|
WO1997001337A1
(en)
*
|
1995-06-29 |
1997-01-16 |
Mcneil-Ppc, Inc. |
The combination of topical nasal antihistamines and topical nasal steroids
|
DE19528145A1
(de)
|
1995-08-01 |
1997-02-06 |
Boehringer Ingelheim Kg |
Neue Arzneimittel und ihre Verwendung
|
GB9521696D0
(en)
|
1995-10-23 |
1996-01-03 |
Bayer Ag |
Combination of LTD4 receptor antagonists with glucocorticosteriods
|
US6017963A
(en)
*
|
1995-11-14 |
2000-01-25 |
Euro-Celtique, S.A. |
Formulation for intranasal administration
|
US5792758A
(en)
|
1995-12-08 |
1998-08-11 |
G. D. Searle & Co. |
Steroid nitrite ester derivatives useful as anti-inflammatory drugs
|
US5707984A
(en)
|
1995-12-08 |
1998-01-13 |
G. D. Searle & Co. |
Steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs
|
EP0780127A1
(de)
*
|
1995-12-19 |
1997-06-25 |
The Procter & Gamble Company |
Nasenspray enthaltend einen Steroid und einen Antihistamin
|
ES2150150T3
(es)
|
1995-12-29 |
2000-11-16 |
Glaxo Group Ltd |
Derivados de lactona de derivados de 17-beta-carboxi, carbonato y amida androstano.
|
DK0943326T4
(da)
|
1996-02-27 |
2007-01-22 |
Teijin Ltd |
Pulveragtigt præparat til nasal administration
|
US5985862A
(en)
|
1996-05-02 |
1999-11-16 |
G.D. Searle & Co. |
Pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
|
US5981517A
(en)
*
|
1996-05-09 |
1999-11-09 |
Soft Drugs, Inc. |
Androstene derivatives
|
AU3153797A
(en)
|
1996-06-04 |
1998-01-05 |
Procter & Gamble Company, The |
A nasal spray containing an intranasal steroid and an antihistamine
|
US5976573A
(en)
|
1996-07-03 |
1999-11-02 |
Rorer Pharmaceutical Products Inc. |
Aqueous-based pharmaceutical composition
|
GB9622173D0
(en)
|
1996-10-24 |
1996-12-18 |
Glaxo Group Ltd |
Particulate Products
|
FR2756739B1
(fr)
|
1996-12-05 |
2000-04-28 |
Astra Ab |
Nouvelle formulation de budesonide
|
TW503113B
(en)
|
1997-01-16 |
2002-09-21 |
Senju Pharma Co |
Aqueous suspension for nasal administration
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
US5830490A
(en)
|
1997-04-04 |
1998-11-03 |
Weinstein; Robert E. |
Method and device for organizing and coordinating the combined use of topical aerosols and oral medications for the treatment of disorders
|
JP2001524108A
(ja)
*
|
1997-04-30 |
2001-11-27 |
ワーナー−ランバート・カンパニー |
局所経鼻抗炎症組成物
|
ATE260931T1
(de)
|
1997-06-30 |
2004-03-15 |
Glaxo Group Ltd |
Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität
|
EP0903151A1
(de)
|
1997-09-22 |
1999-03-24 |
ASTA Medica Aktiengesellschaft |
Verwendung von Kombinationen enthaltend nichtsedierende Antihistaminika und Alfa-Adrenergische Agonisten für die topische Behandlung von Rhinitis/Konjunktivitis sowie Erkältungs- und Grippe-Symptomen
|
US5972327A
(en)
|
1997-10-22 |
1999-10-26 |
Lin; Matthew M. |
Method of treating allergic rhinitis by delivering medication via the nasal vestibules
|
SE9704186D0
(sv)
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New composition of matter
|
SE9704833D0
(sv)
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New formulation
|
US5972920A
(en)
*
|
1998-02-12 |
1999-10-26 |
Dermalogix Partners, Inc. |
Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
|
US6506766B1
(en)
|
1998-02-13 |
2003-01-14 |
Abbott Laboratories |
Glucocortiocoid-selective antinflammatory agents
|
FR2779841B1
(fr)
*
|
1998-06-15 |
2006-08-04 |
Peugeot |
Procede et dispositif de commande d'un actionneur electrique d'activation d'un systeme fonctionnel
|
US6241969B1
(en)
|
1998-06-26 |
2001-06-05 |
Elan Corporation Plc |
Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
|
US6319513B1
(en)
*
|
1998-08-24 |
2001-11-20 |
The Procter & Gamble Company |
Oral liquid mucoadhesive compounds
|
US6136294C1
(en)
|
1998-09-22 |
2002-09-24 |
Aeropharm Technology Inc |
Amino acid stabilized medical aerosol formulation
|
SE9803770D0
(sv)
|
1998-11-05 |
1998-11-05 |
Astra Ab |
Dry powder pharmaceutical formulation
|
US6261539B1
(en)
*
|
1998-12-10 |
2001-07-17 |
Akwete Adjei |
Medicinal aerosol formulation
|
US6294153B1
(en)
*
|
1998-12-21 |
2001-09-25 |
Generex Pharmaceuticals, Inc. |
Aerosol pharmaceutical formulation for pulmonary and nasal delivery
|
GB9828721D0
(en)
|
1998-12-24 |
1999-02-17 |
Glaxo Group Ltd |
Novel apparatus and process
|
EP1020233A1
(de)
|
1999-01-13 |
2000-07-19 |
The Procter & Gamble Company |
Dosierungs- und Verteilungssystem
|
GB9903759D0
(en)
|
1999-02-18 |
1999-04-14 |
Novartis Ag |
Organic compounds
|
AU3703900A
(en)
|
1999-02-24 |
2000-09-14 |
Nitromed, Inc. |
Nitrosated and nitrosylated steroids for the treatment of cardiovascular diseases and disorders
|
CZ304203B6
(cs)
|
1999-04-30 |
2014-01-02 |
Pfizer Products Inc. |
Modulátor glukokortikoidního receptoru a léčivo pro léčbu zánětlivé choroby s jeho obsahem
|
US6395300B1
(en)
*
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US20020061281A1
(en)
*
|
1999-07-06 |
2002-05-23 |
Osbakken Robert S. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
US20020081266A1
(en)
*
|
1999-08-20 |
2002-06-27 |
Norton Healthcare Ltd. |
Spray dried powders for pulmonary or nasal administration
|
EP1212619B1
(de)
|
1999-09-14 |
2007-05-23 |
Xenoport, Inc. |
Substrate und screeningverfahren für transportproteine
|
DE19947234A1
(de)
|
1999-09-30 |
2001-04-05 |
Asta Medica Ag |
Neue Kombination von Loteprednol und Antihistaminika
|
US6596261B1
(en)
|
2000-01-25 |
2003-07-22 |
Aeropharm Technology Incorporated |
Method of administering a medicinal aerosol formulation
|
AU3275301A
(en)
|
2000-01-28 |
2001-08-07 |
Rohm And Haas Company |
Enhanced propertied pharmaceuticals
|
EA005028B1
(ru)
|
2000-01-31 |
2004-10-28 |
Пфайзер Продактс Инк. |
Пиримидинкарбоксамиды, используемые в качестве ингибиторов изозимов pde4
|
US6565832B1
(en)
|
2000-01-31 |
2003-05-20 |
Schering-Plough Healthcare Products, Inc. |
Spray composition with reduced dripping
|
DE10007203A1
(de)
|
2000-02-17 |
2001-08-23 |
Asta Medica Ag |
Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
|
US20020133032A1
(en)
|
2000-02-25 |
2002-09-19 |
Jufang Barkalow |
Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
|
GB0009592D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Respiratory combinations
|
GB0009606D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Therapeutic combinations
|
GB0009591D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Medical combinations
|
GB0009583D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Respiratory formulations
|
GB0015876D0
(en)
*
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
GB0016040D0
(en)
|
2000-06-29 |
2000-08-23 |
Glaxo Group Ltd |
Novel process for preparing crystalline particles
|
GB0017988D0
(en)
|
2000-07-21 |
2000-09-13 |
Glaxo Group Ltd |
Novel process
|
CA2412376A1
(en)
|
2000-07-26 |
2002-01-31 |
Onkar N. Singh |
Pharmaceutical suspension compositions lacking a polymeric suspending agent
|
CA2417973A1
(en)
|
2000-08-04 |
2002-02-14 |
Longwood Pharmaceutical Research, Inc. |
Formulations of mometasone and a bronchodilator for pulmonary administration
|
US6750210B2
(en)
*
|
2000-08-05 |
2004-06-15 |
Smithkline Beecham Corporation |
Formulation containing novel anti-inflammatory androstane derivative
|
US6777399B2
(en)
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
US6787532B2
(en)
*
|
2000-08-05 |
2004-09-07 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivatives
|
US6858593B2
(en)
*
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
US6777400B2
(en)
*
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
GB0019172D0
(en)
|
2000-08-05 |
2000-09-27 |
Glaxo Group Ltd |
Novel compounds
|
AR032361A1
(es)
|
2000-08-05 |
2003-11-05 |
Glaxo Group Ltd |
Derivados de androstano y sales y solvatos de los mismos, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que comprenden tales compuestos, proceso para la preparacion de dichos compuestos, e intermediarios utiles en la preparacion de tales compuestos
|
US6858596B2
(en)
*
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivative
|
US6759398B2
(en)
*
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
JP2002053485A
(ja)
|
2000-08-08 |
2002-02-19 |
Oshida Tetsuo |
アレルギー性疾患用医薬組成物
|
AR032362A1
(es)
|
2000-08-14 |
2003-11-05 |
Glaxo Group Ltd |
Formulacion topica estable de una emulsion de aceite en agua y proceso para su preparacion
|
DE60124576T2
(de)
|
2000-09-29 |
2007-06-21 |
Glaxo Group Ltd., Greenford |
Verbindungen verwendbar für die behandlung von entzündungskrankheiten
|
ZA200108461B
(en)
*
|
2000-10-27 |
2002-06-06 |
Celanese Chem Europe Gmbh |
Process of telomerizing conjugated dienes.
|
US7776315B2
(en)
*
|
2000-10-31 |
2010-08-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions based on anticholinergics and additional active ingredients
|
EA009068B1
(ru)
|
2000-10-31 |
2007-10-26 |
Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг |
Ингаляционная композиция в виде раствора с солью тиотропия
|
CA2733294C
(en)
|
2000-10-31 |
2011-12-20 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical combination of a tiotropium salt and ciclesonide
|
CA2438799C
(en)
|
2000-12-22 |
2009-09-01 |
Ssp Co., Ltd. |
Preventative of therapeutic agent for inflammatory respiratory tract disease
|
US20020132803A1
(en)
|
2001-01-05 |
2002-09-19 |
Mahendra Dedhiya |
Fluticasone suspension formulation, spray pattern method, and nasal spray apparatus
|
US6583180B2
(en)
*
|
2001-02-14 |
2003-06-24 |
Abbott Laboratories |
Glucocorticoid receptor modulators
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
GB0105560D0
(en)
*
|
2001-03-07 |
2001-04-25 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
DE60220887T2
(de)
|
2001-03-08 |
2008-02-28 |
Glaxo Group Ltd., Greenford |
Agonisten von beta-adrenorezeptoren
|
US7045658B2
(en)
|
2001-03-22 |
2006-05-16 |
Glaxo Group Limited |
Formailide derivatives as beta2-adrenoreceptor agonists
|
UA77656C2
(en)
|
2001-04-07 |
2007-01-15 |
Glaxo Group Ltd |
S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
|
AU2002303425A1
(en)
|
2001-04-24 |
2002-11-05 |
Epigenesis Pharmaceuticals, Inc. |
Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
|
WO2002088167A1
(en)
|
2001-04-30 |
2002-11-07 |
Glaxo Group Limited |
Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
|
JP2005500290A
(ja)
|
2001-06-12 |
2005-01-06 |
グラクソ グループ リミテッド |
抗炎症性の、17β−カルボチオアートアンドロスタン誘導体である17α複素環エステル
|
DE10130371A1
(de)
|
2001-06-23 |
2003-01-02 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
|
US20030018019A1
(en)
*
|
2001-06-23 |
2003-01-23 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
|
AU2002321884A1
(en)
|
2001-08-03 |
2003-02-24 |
Smithkline Beecham Corporation |
A method for preparing fluticasone derivatives
|
GB0124523D0
(en)
|
2001-10-12 |
2001-12-05 |
Glaxo Group Ltd |
Pharmaceutical combination
|
GB0125259D0
(en)
|
2001-10-20 |
2001-12-12 |
Glaxo Group Ltd |
Novel compounds
|
EP1451577A4
(de)
|
2001-11-05 |
2006-03-15 |
Brigham & Womens Hospital |
Lösliches cd40l(cd154) als prognosemarker für atheroskleroseerkrankungen
|
GB0127160D0
(en)
|
2001-11-12 |
2002-01-02 |
Glaxo Group Ltd |
Novel compounds
|
WO2003042229A1
(en)
|
2001-11-12 |
2003-05-22 |
Glaxo Group Limited |
Non-aromatic heterocyclic esters of furan-2-one-esters of 17.beta.-carboxyl or 17.beta.-carbothio glucocorticoids
|
WO2003048181A1
(en)
|
2001-12-01 |
2003-06-12 |
Glaxo Group Limited |
17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
|
WO2003049770A1
(en)
*
|
2001-12-05 |
2003-06-19 |
Alcon, Inc. |
Use of an h1 antagonist and a safe steroid to treat rhinitis
|
AU2003202044A1
(en)
|
2002-01-15 |
2003-09-09 |
Glaxo Group Limited |
17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
|
WO2003062259A2
(en)
|
2002-01-21 |
2003-07-31 |
Glaxo Group Limited |
Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
|
GB0202216D0
(en)
|
2002-01-31 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
WO2003066033A1
(en)
|
2002-02-04 |
2003-08-14 |
Glaxo Group Limited |
Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
|
GB0202635D0
(en)
|
2002-02-05 |
2002-03-20 |
Glaxo Wellcome Mfg Pte Ltd |
Formulation containing novel anti-inflammatory androstane derivative
|
DE10216429A1
(de)
|
2002-04-12 |
2003-10-23 |
Boehringer Ingelheim Pharma |
Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
|
JP3691459B2
(ja)
*
|
2002-06-14 |
2005-09-07 |
久光メディカル株式会社 |
粉末状吸入剤組成物
|
GB2389530B
(en)
|
2002-06-14 |
2007-01-10 |
Cipla Ltd |
Pharmaceutical compositions
|
GB0217504D0
(en)
|
2002-07-29 |
2002-09-04 |
Novartis Ag |
Organic compounds
|
US7244742B2
(en)
*
|
2002-08-17 |
2007-07-17 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
|
ES2393864T3
(es)
|
2002-08-30 |
2012-12-28 |
Nycomed Gmbh |
El uso de la asociación de ciclesonida y antihistaminas para el tratamiento de rinitis alérgica
|
US20040235807A1
(en)
*
|
2003-05-21 |
2004-11-25 |
Weinrich Karl P. |
Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea
|
GB0316290D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
US20050192261A1
(en)
*
|
2003-09-15 |
2005-09-01 |
Jost-Price Edward R. |
Methods and reagents for the treatment of immunoinflammatory disorders
|
WO2005030331A1
(en)
*
|
2003-09-26 |
2005-04-07 |
Fairfield Clinical Trials, Llc |
Combination antihistamine medication
|
US20070020330A1
(en)
*
|
2004-11-24 |
2007-01-25 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
PT2522365T
(pt)
|
2004-11-24 |
2017-02-08 |
Meda Pharmaceuticals Inc |
Composições que compreendem azelastina e seus métodos de utilização
|
US8758816B2
(en)
*
|
2004-11-24 |
2014-06-24 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
ATE517908T1
(de)
|
2005-01-10 |
2011-08-15 |
Glaxo Group Ltd |
Androstan-17-alpha-carbonat-derivate zur verwendung bei der behandlung allergischer und entzündlicher zustände
|
GB0507165D0
(en)
|
2005-04-08 |
2005-05-18 |
Glaxo Group Ltd |
Novel crystalline pharmaceutical product
|
WO2007061454A1
(en)
|
2005-11-22 |
2007-05-31 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
GB0615108D0
(en)
*
|
2006-07-28 |
2006-09-06 |
Glaxo Group Ltd |
Novel formulations
|
US20120022032A1
(en)
*
|
2008-10-10 |
2012-01-26 |
Schering Corporation |
Corticosteroid compositions and methods of treatments thereof
|